ONXX

ONYX PHARMACEUTICALS INC

ONXX

Delisted

ONXX was delisted on the 30th of September, 2013.

258 hedge funds and large institutions have $7.38B invested in ONYX PHARMACEUTICALS INC in 2013 Q3 according to their latest regulatory filings, with 83 funds opening new positions, 54 increasing their positions, 104 reducing their positions, and 95 closing their positions.

2013 Q4 2013 Q3 2013 Q2

Holders

258

Holders Change

-14

Holders Change %

-5.15%

% of All Funds

8.37%

Holding in Top 10

Holding in Top 10 Change

+34

Holding in Top 10 Change %

+283.33%

% of All Funds

1.49%

New

Increased

Reduced

104

Closed

Calls

$1.26B

Puts

$810M

Net Calls

+$448M

Net Calls Change

+$468M

Top Buyers

1	DKCM 1 Davidson Kempner Capital Management New York	$393M
2	HI 2 HBK Investments Dallas, Texas	$339M
3	3 Adage Capital Partners Boston, Massachusetts	$512M
4	ACPU 4 Arrowgrass Capital Partners (US) Dover, Delaware	$246M
5	FCM 5 Farallon Capital Management San Francisco, California	$252M

Top Sellers

1	1 BNP Paribas Financial Markets Paris, France	$997K
2	2 Fidelity Investments Boston, Massachusetts	$75.5M
3	3 JPMorgan Chase & Co New York	$60.1M
4	4 T. Rowe Price Associates Baltimore, Maryland	$44.1M
5	5 Wellington Management Group Boston, Massachusetts	$145M

#	Name	Market Value	Shares	Shares Change	Shares Change %
26	WIC 26 Water Island Capital New York	$71.2M	571,429	+571,429	New
27	PA 27 Perceptive Advisors New York	$69.5M	556,944	+556,944	New
28	PSAMP 28 P. Schoenfeld Asset Management (PSAM) New York	$68.6M	550,000	+550,000	New
29	MP 29 Manikay Partners New York	$65.5M	525,000	+525,000	New
30	LM 30 Litespeed Management New York	$65.3M	523,368	+523,368	New
31	TAL 31 TIG Advisors LLC New York	$63.8M	511,752	+511,752	New
32	UOC 32 UBS O'Connor Chicago, Illinois	$60.5M	484,886	+444,886	+1,112%
33	33 JPMorgan Chase & Co New York	$60.1M	482,336	-5,813,966	-92%
34	MG 34 Meditor Group Hamilton, Bermuda	$54.2M	435,000	-527,103	-55%
35	35 UBS AM Chicago, Illinois	$53.4M	427,962	-67,458	-14%
36	HMC 36 Harvard Management Company Boston, Massachusetts	$50.5M	405,000	+405,000	New
37	37 Jennison Associates New York	$48.1M	386,040	-1,017,711	-72%
38	BG 38 BlackRock Group London, United Kingdom	$46.3M	370,913	-81,367	-18%
39	39 AQR Capital Management Greenwich, Connecticut	$45.6M	365,960	+352,752	+2,671%
40	40 Bank of New York Mellon New York	$45.6M	365,371	-823,399	-69%
41	41 T. Rowe Price Associates Baltimore, Maryland	$44.1M	353,850	-4,584,044	-93%
42	CC 42 Carlson Capital Dallas, Texas	$43M	345,000	+345,000	New
43	PAI 43 Palo Alto Investors Palo Alto, California	$42.8M	343,473	-981,642	-74%
44	AAA 44 Alpine Associates Advisors Englewood Cliffs, New Jersey	$42.8M	343,100	+343,100	New
45	45 Geode Capital Management Boston, Massachusetts	$42.4M	340,496	+43,977	+15%
46	BB 46 BB Biotech Schaffhausen, Switzerland	$42.4M	339,870	-206,630	-38%
47	47 Deutsche Bank Frankfurt Am Main Ge, Germany	$41.2M	330,341	-394,937	-54%
48	GCIA 48 Gabelli & Co Investment Advisers Rye, New York	$38.1M	305,170	+305,170	New
49	AIM 49 Allen Investment Management New York	$37.7M	302,000	+302,000	New
50	GIM 50 Granahan Investment Management Waltham, Massachusetts	$37.5M	300,800	-232,000	-44%

ONYX PHARMACEUTICALS INC ONXX

Top Buyers

Top Sellers

ONYX PHARMACEUTICALS INC

ONXX